India Cold Chain for Pharma Logistics Market

India Cold Chain for Pharma Logistics Market is worth USD 2.5 billion, fueled by rising need for temperature-sensitive pharmaceuticals and infrastructure improvements.

Region:Asia

Author(s):Rebecca

Product Code:KRAB2960

Pages:92

Published On:October 2025

About the Report

Base Year 2024

India Cold Chain for Pharma Logistics Market Overview

  • The India Cold Chain for Pharma Logistics Market is valued at USD 2.5 billion, based on a five-year historical analysis. This growth is primarily driven by the increasing demand for temperature-sensitive pharmaceuticals, including vaccines and biologics, alongside the expansion of the pharmaceutical industry in India. The rising awareness of the importance of maintaining the integrity of pharmaceutical products during transportation and storage has further fueled market growth.
  • Key players in this market include major cities such as Mumbai, Delhi, and Bengaluru, which dominate due to their robust infrastructure, proximity to pharmaceutical manufacturing hubs, and advanced logistics capabilities. These cities serve as critical nodes for distribution, ensuring efficient cold chain management and timely delivery of pharmaceutical products across the country.
  • In 2023, the Indian government implemented the National Logistics Policy, which aims to enhance the efficiency of the logistics sector, including cold chain logistics. This policy focuses on improving infrastructure, reducing logistics costs, and promoting the adoption of technology in cold chain operations, thereby supporting the growth of the cold chain for pharmaceuticals.
India Cold Chain for Pharma Logistics Market Size

India Cold Chain for Pharma Logistics Market Segmentation

By Type:The market is segmented into various types, including Refrigerated Trucks, Cold Storage Facilities, Temperature-Controlled Packaging, Monitoring Devices, and Others. Among these, Cold Storage Facilities are currently dominating the market due to the increasing need for large-scale storage solutions for temperature-sensitive pharmaceuticals. The rise in biologics and vaccines, especially during health crises, has led to a surge in demand for these facilities, which ensure the integrity and efficacy of products throughout their shelf life.

India Cold Chain for Pharma Logistics Market segmentation by Type.

By End-User:The end-user segmentation includes Pharmaceutical Manufacturers, Hospitals and Clinics, Distributors and Wholesalers, Retail Pharmacies, and Others. Pharmaceutical Manufacturers are the leading end-users in the market, driven by the need for efficient distribution of temperature-sensitive products. The increasing production of vaccines and biologics has necessitated robust cold chain logistics solutions, making manufacturers a critical segment in ensuring product safety and compliance with regulatory standards.

India Cold Chain for Pharma Logistics Market segmentation by End-User.

India Cold Chain for Pharma Logistics Market Competitive Landscape

The India Cold Chain for Pharma Logistics Market is characterized by a dynamic mix of regional and international players. Leading participants such as Blue Dart Express Limited, DHL Supply Chain India, Gati Limited, ColdEX Logistics, Snowman Logistics Limited, Mahindra Logistics, TCI Cold Chain Solutions, Xpressbees Logistics, Allcargo Logistics Limited, Future Supply Chain Solutions, Aegis Logistics Limited, Sical Logistics Limited, Shree Maruti Courier Services, Om Logistics, Delhivery Limited contribute to innovation, geographic expansion, and service delivery in this space.

Blue Dart Express Limited

1983

Mumbai, India

DHL Supply Chain India

2000

Bengaluru, India

Gati Limited

1989

Hyderabad, India

ColdEX Logistics

2001

Mumbai, India

Snowman Logistics Limited

1993

Bengaluru, India

Company

Establishment Year

Headquarters

Group Size (Large, Medium, or Small as per industry convention)

Revenue Growth Rate

Market Penetration Rate

Customer Retention Rate

Operational Efficiency Ratio

Pricing Strategy

India Cold Chain for Pharma Logistics Market Industry Analysis

Growth Drivers

  • Increasing Demand for Temperature-Sensitive Pharmaceuticals:The Indian pharmaceutical market is projected to reach $65 billion in future, driven by a growing population and rising healthcare needs. With approximately 30% of pharmaceuticals requiring temperature control, the demand for cold chain logistics is surging. The increasing prevalence of chronic diseases, which necessitate temperature-sensitive medications, further fuels this demand, highlighting the critical role of cold chain logistics in ensuring product efficacy and safety.
  • Expansion of the Pharmaceutical Industry in India:The Indian pharmaceutical industry is expected to grow at a rate of 12% annually, reaching $100 billion in future. This growth is supported by a robust manufacturing base and increasing exports, which accounted for $24.4 billion in the previous fiscal year. As the industry expands, the need for efficient cold chain logistics becomes paramount to maintain the integrity of temperature-sensitive products throughout the supply chain, ensuring compliance with international standards.
  • Government Initiatives to Enhance Healthcare Infrastructure:The Indian government has allocated $1.5 billion for the National Health Mission in future, focusing on improving healthcare infrastructure, including cold chain logistics. Initiatives like the Pradhan Mantri Bhartiya Janaushadhi Pariyojana aim to increase access to affordable medicines, necessitating efficient cold chain systems. These investments are crucial for developing a reliable logistics network that can support the growing pharmaceutical sector and enhance healthcare delivery across the country.

Market Challenges

  • High Operational Costs Associated with Cold Chain Logistics:The operational costs for cold chain logistics in India can reach up to 30% higher than standard logistics due to specialized equipment and energy requirements. With energy costs projected to rise by 10% in future, maintaining cost efficiency becomes a significant challenge for logistics providers. This financial burden can limit the scalability of cold chain operations, particularly for smaller players in the market.
  • Limited Infrastructure in Rural Areas:Approximately 70% of India's population resides in rural areas, where cold chain infrastructure is severely lacking. According to the Ministry of Health and Family Welfare, only 20% of rural healthcare facilities have adequate cold storage capabilities. This gap poses a significant challenge in ensuring the distribution of temperature-sensitive pharmaceuticals, leading to potential wastage and compromised patient care in underserved regions.

India Cold Chain for Pharma Logistics Market Future Outlook

The future of the cold chain logistics market in India appears promising, driven by technological advancements and increasing investments in infrastructure. The adoption of IoT and automation is expected to enhance operational efficiency, enabling real-time monitoring and reducing spoilage rates. Additionally, as the government continues to support healthcare initiatives, the cold chain sector will likely see significant growth, ensuring that temperature-sensitive pharmaceuticals reach patients effectively and safely across diverse regions.

Market Opportunities

  • Growth in E-commerce for Pharmaceuticals:The e-commerce sector for pharmaceuticals is projected to reach $5 billion in future, driven by increased online shopping trends. This growth presents a significant opportunity for cold chain logistics providers to develop specialized solutions that cater to the unique needs of temperature-sensitive products, ensuring timely and safe delivery to consumers.
  • Technological Advancements in Cold Chain Solutions:Innovations such as blockchain for supply chain transparency and advanced temperature monitoring systems are gaining traction. These technologies can enhance the reliability of cold chain logistics, reducing losses and improving compliance with regulatory standards. As these solutions become more accessible, they will create new opportunities for logistics providers to differentiate themselves in a competitive market.

Scope of the Report

SegmentSub-Segments
By Type

Refrigerated Trucks

Cold Storage Facilities

Temperature-Controlled Packaging

Monitoring Devices

Others

By End-User

Pharmaceutical Manufacturers

Hospitals and Clinics

Distributors and Wholesalers

Retail Pharmacies

Others

By Region

North India

South India

East India

West India

By Application

Vaccines

Biologics

Blood Products

Other Pharmaceuticals

By Distribution Mode

Direct Distribution

Third-Party Logistics

E-commerce Platforms

Others

By Investment Source

Private Investments

Government Funding

Foreign Direct Investment (FDI)

Public-Private Partnerships (PPP)

By Policy Support

Subsidies for Cold Chain Infrastructure

Tax Incentives for Cold Chain Operators

Grants for Technology Adoption

Others

Key Target Audience

Investors and Venture Capitalist Firms

Government and Regulatory Bodies (e.g., Ministry of Health and Family Welfare, Food Safety and Standards Authority of India)

Pharmaceutical Manufacturers

Cold Chain Logistics Providers

Healthcare Institutions and Hospitals

Pharmaceutical Distributors and Wholesalers

Biotechnology Companies

Supply Chain Management Firms

Players Mentioned in the Report:

Blue Dart Express Limited

DHL Supply Chain India

Gati Limited

ColdEX Logistics

Snowman Logistics Limited

Mahindra Logistics

TCI Cold Chain Solutions

Xpressbees Logistics

Allcargo Logistics Limited

Future Supply Chain Solutions

Aegis Logistics Limited

Sical Logistics Limited

Shree Maruti Courier Services

Om Logistics

Delhivery Limited

Table of Contents

Market Assessment Phase

1. Executive Summary and Approach


2. India Cold Chain for Pharma Logistics Market Overview

2.1 Key Insights and Strategic Recommendations

2.2 India Cold Chain for Pharma Logistics Market Overview

2.3 Definition and Scope

2.4 Evolution of Market Ecosystem

2.5 Timeline of Key Regulatory Milestones

2.6 Value Chain & Stakeholder Mapping

2.7 Business Cycle Analysis

2.8 Policy & Incentive Landscape


3. India Cold Chain for Pharma Logistics Market Analysis

3.1 Growth Drivers

3.1.1 Increasing demand for temperature-sensitive pharmaceuticals
3.1.2 Expansion of the pharmaceutical industry in India
3.1.3 Government initiatives to enhance healthcare infrastructure
3.1.4 Rising awareness of the importance of cold chain logistics

3.2 Market Challenges

3.2.1 High operational costs associated with cold chain logistics
3.2.2 Limited infrastructure in rural areas
3.2.3 Regulatory compliance complexities
3.2.4 Shortage of skilled workforce in cold chain management

3.3 Market Opportunities

3.3.1 Growth in e-commerce for pharmaceuticals
3.3.2 Technological advancements in cold chain solutions
3.3.3 Partnerships with healthcare providers
3.3.4 Expansion into untapped markets

3.4 Market Trends

3.4.1 Adoption of IoT for real-time monitoring
3.4.2 Increasing use of automated cold storage solutions
3.4.3 Focus on sustainability in cold chain operations
3.4.4 Growth of third-party logistics providers

3.5 Government Regulation

3.5.1 Guidelines for temperature control in pharmaceutical transport
3.5.2 Compliance with WHO standards for cold chain logistics
3.5.3 Incentives for cold chain infrastructure development
3.5.4 Regulations on packaging and labeling of temperature-sensitive products

4. SWOT Analysis


5. Stakeholder Analysis


6. Porter's Five Forces Analysis


7. India Cold Chain for Pharma Logistics Market Market Size, 2019-2024

7.1 By Value

7.2 By Volume

7.3 By Average Selling Price


8. India Cold Chain for Pharma Logistics Market Segmentation

8.1 By Type

8.1.1 Refrigerated Trucks
8.1.2 Cold Storage Facilities
8.1.3 Temperature-Controlled Packaging
8.1.4 Monitoring Devices
8.1.5 Others

8.2 By End-User

8.2.1 Pharmaceutical Manufacturers
8.2.2 Hospitals and Clinics
8.2.3 Distributors and Wholesalers
8.2.4 Retail Pharmacies
8.2.5 Others

8.3 By Region

8.3.1 North India
8.3.2 South India
8.3.3 East India
8.3.4 West India

8.4 By Application

8.4.1 Vaccines
8.4.2 Biologics
8.4.3 Blood Products
8.4.4 Other Pharmaceuticals

8.5 By Distribution Mode

8.5.1 Direct Distribution
8.5.2 Third-Party Logistics
8.5.3 E-commerce Platforms
8.5.4 Others

8.6 By Investment Source

8.6.1 Private Investments
8.6.2 Government Funding
8.6.3 Foreign Direct Investment (FDI)
8.6.4 Public-Private Partnerships (PPP)

8.7 By Policy Support

8.7.1 Subsidies for Cold Chain Infrastructure
8.7.2 Tax Incentives for Cold Chain Operators
8.7.3 Grants for Technology Adoption
8.7.4 Others

9. India Cold Chain for Pharma Logistics Market Competitive Analysis

9.1 Market Share of Key Players

9.2 Cross Comparison of Key Players

9.2.1 Company Name
9.2.2 Group Size (Large, Medium, or Small as per industry convention)
9.2.3 Revenue Growth Rate
9.2.4 Market Penetration Rate
9.2.5 Customer Retention Rate
9.2.6 Operational Efficiency Ratio
9.2.7 Pricing Strategy
9.2.8 Service Level Agreement Compliance
9.2.9 Inventory Turnover Rate
9.2.10 Delivery Accuracy Rate

9.3 SWOT Analysis of Top Players

9.4 Pricing Analysis

9.5 Detailed Profile of Major Companies

9.5.1 Blue Dart Express Limited
9.5.2 DHL Supply Chain India
9.5.3 Gati Limited
9.5.4 ColdEX Logistics
9.5.5 Snowman Logistics Limited
9.5.6 Mahindra Logistics
9.5.7 TCI Cold Chain Solutions
9.5.8 Xpressbees Logistics
9.5.9 Allcargo Logistics Limited
9.5.10 Future Supply Chain Solutions
9.5.11 Aegis Logistics Limited
9.5.12 Sical Logistics Limited
9.5.13 Shree Maruti Courier Services
9.5.14 Om Logistics
9.5.15 Delhivery Limited

10. India Cold Chain for Pharma Logistics Market End-User Analysis

10.1 Procurement Behavior of Key Ministries

10.1.1 Ministry of Health and Family Welfare
10.1.2 Ministry of Pharmaceuticals
10.1.3 Ministry of Commerce and Industry

10.2 Corporate Spend on Infrastructure & Energy

10.2.1 Investment in Cold Storage Facilities
10.2.2 Expenditure on Transportation Logistics
10.2.3 Budget Allocation for Technology Upgrades

10.3 Pain Point Analysis by End-User Category

10.3.1 Pharmaceutical Manufacturers
10.3.2 Hospitals and Clinics
10.3.3 Distributors and Wholesalers

10.4 User Readiness for Adoption

10.4.1 Awareness of Cold Chain Importance
10.4.2 Willingness to Invest in Technology
10.4.3 Training and Skill Development Needs

10.5 Post-Deployment ROI and Use Case Expansion

10.5.1 Measurement of Cost Savings
10.5.2 Evaluation of Service Quality Improvements
10.5.3 Potential for Market Expansion

11. India Cold Chain for Pharma Logistics Market Future Size, 2025-2030

11.1 By Value

11.2 By Volume

11.3 By Average Selling Price


Go-To-Market Strategy Phase

1. Whitespace Analysis + Business Model Canvas

1.1 Identification of Market Gaps

1.2 Value Proposition Development

1.3 Revenue Model Structuring

1.4 Key Partnerships and Resources

1.5 Customer Segmentation

1.6 Cost Structure Analysis

1.7 Channels of Distribution


2. Marketing and Positioning Recommendations

2.1 Branding Strategies

2.2 Product USPs


3. Distribution Plan

3.1 Urban Retail vs Rural NGO Tie-ups


4. Channel & Pricing Gaps

4.1 Underserved Routes

4.2 Pricing Bands


5. Unmet Demand & Latent Needs

5.1 Category Gaps

5.2 Consumer Segments


6. Customer Relationship

6.1 Loyalty Programs

6.2 After-sales Service


7. Value Proposition

7.1 Sustainability

7.2 Integrated Supply Chains


8. Key Activities

8.1 Regulatory Compliance

8.2 Branding

8.3 Distribution Setup


9. Entry Strategy Evaluation

9.1 Domestic Market Entry Strategy

9.1.1 Product Mix
9.1.2 Pricing Band
9.1.3 Packaging

9.2 Export Entry Strategy

9.2.1 Target Countries
9.2.2 Compliance Roadmap

10. Entry Mode Assessment

10.1 JV

10.2 Greenfield

10.3 M&A

10.4 Distributor Model


11. Capital and Timeline Estimation

11.1 Capital Requirements

11.2 Timelines


12. Control vs Risk Trade-Off

12.1 Ownership vs Partnerships


13. Profitability Outlook

13.1 Breakeven Analysis

13.2 Long-term Sustainability


14. Potential Partner List

14.1 Distributors

14.2 JVs

14.3 Acquisition Targets


15. Execution Roadmap

15.1 Phased Plan for Market Entry

15.1.1 Market Setup
15.1.2 Market Entry
15.1.3 Growth Acceleration
15.1.4 Scale & Stabilize

15.2 Key Activities and Milestones

15.2.1 Activity Planning
15.2.2 Milestone Tracking

Research Methodology

ApproachModellingSample

Phase 1: Approach1

Desk Research

  • Analysis of industry reports from the Indian Pharmaceutical Association and logistics bodies
  • Review of government publications on cold chain infrastructure and regulations
  • Examination of market trends through academic journals and white papers on pharmaceutical logistics

Primary Research

  • Interviews with logistics managers at pharmaceutical companies to understand operational challenges
  • Surveys with cold chain service providers to gather insights on service offerings and pricing
  • Field visits to cold storage facilities to assess infrastructure and technology used

Validation & Triangulation

  • Cross-validation of data from multiple sources including industry reports and expert interviews
  • Triangulation of findings from primary and secondary research to ensure consistency
  • Sanity checks through expert panel reviews comprising industry veterans and analysts

Phase 2: Market Size Estimation1

Top-down Assessment

  • Estimation of the total addressable market based on national pharmaceutical sales data
  • Segmentation of the market by therapeutic areas and temperature-sensitive products
  • Incorporation of government initiatives aimed at enhancing cold chain logistics

Bottom-up Modeling

  • Collection of data on cold chain capacity from leading logistics providers
  • Operational cost analysis based on service pricing and delivery frequency
  • Volume estimates derived from pharmaceutical distribution channels and demand forecasts

Forecasting & Scenario Analysis

  • Multi-variable regression analysis incorporating growth rates of the pharmaceutical sector
  • Scenario modeling based on potential regulatory changes and technological advancements
  • Development of baseline, optimistic, and pessimistic forecasts through 2030

Phase 3: CATI Sample Composition1

Scope Item/SegmentSample SizeTarget Respondent Profiles
Pharmaceutical Manufacturers150Supply Chain Managers, Quality Assurance Heads
Cold Chain Service Providers100Operations Directors, Logistics Coordinators
Regulatory Bodies50Policy Makers, Compliance Officers
Healthcare Institutions80Pharmacy Managers, Procurement Specialists
Technology Providers for Cold Chain70Product Managers, R&D Engineers

Frequently Asked Questions

What is the current value of the India Cold Chain for Pharma Logistics Market?

The India Cold Chain for Pharma Logistics Market is valued at approximately USD 2.5 billion, driven by the increasing demand for temperature-sensitive pharmaceuticals, including vaccines and biologics, and the expansion of the pharmaceutical industry in India.

What are the key drivers of growth in the India Cold Chain for Pharma Logistics Market?

Which cities are major players in the India Cold Chain for Pharma Logistics Market?

What types of cold chain solutions are available in the market?

Other Regional/Country Reports

Indonesia Cold Chain for Pharma Logistics Market

Malaysia Cold Chain for Pharma Logistics Market

KSA Cold Chain for Pharma Logistics Market

APAC Cold Chain for Pharma Logistics Market

SEA Cold Chain for Pharma Logistics Market

Vietnam Cold Chain for Pharma Logistics Market

Other Adjacent Reports

Saudi Arabia Pharmaceutical Manufacturing Market Size, Share, Growth Drivers, Trends, Opportunities & Forecast 2025–2030

Philippines Biologics Distribution Market

Japan Vaccine Supply Chain Market

Singapore Temperature-Controlled Packaging Market

Egypt Cold Storage Facilities Market

Kuwait Refrigerated Transportation Market

Philippines Supply Chain Monitoring Devices Market

South Africa Healthcare Logistics Software Market

Thailand E-Pharmacy Delivery Market

Brazil Medical Device Logistics Market

Why Buy From Us?

Refine Robust Result (RRR) Framework
Refine Robust Result (RRR) Framework

What makes us stand out is that our consultants follow Robust, Refine and Result (RRR) methodology. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents' facts and opinions, and Result for presenting data with story.

Our Reach Is Unmatched
Our Reach Is Unmatched

We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.

Shifting the Research Paradigm
Shifting the Research Paradigm

While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.

More Insights-Better Decisions
More Insights-Better Decisions

With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.

Transparency and Trust
Transparency and Trust

Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.

Round the Clock Support
Round the Clock Support

If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.

Why Clients Choose Us?

400000+
Reports in repository
150+
Consulting projects a year
100+
Analysts
8000+
Client Queries in 2022